- Pulsatilla saponin D
-
-
2023-02-24
- CAS:68027-15-6
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
|
| | Hederagenin 3-O-α-L-rhaMnopyranosyl(1→2)-(β-D-glucopyranosyl(1→4))-α-L-arabinopyranoside Basic information |
| | Hederagenin 3-O-α-L-rhaMnopyranosyl(1→2)-(β-D-glucopyranosyl(1→4))-α-L-arabinopyranoside Chemical Properties |
| Melting point | 239-241℃ | | Boiling point | 997.6±65.0 °C(Predicted) | | density | 1.40±0.1 g/cm3 (20 ºC 760 Torr) | | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | | solubility | Methanol (Slightly), Pyridine | | pka | 4.63±0.70(Predicted) | | form | Solid | | color | White to Light Beige |
| | Hederagenin 3-O-α-L-rhaMnopyranosyl(1→2)-(β-D-glucopyranosyl(1→4))-α-L-arabinopyranoside Usage And Synthesis |
| Description | Pulsatilla saponin D is an oleanane-type saponin that has been found in P. koreana and has anticancer activity. It is cytotoxic to A549, SKOV3, SK-MEL-2, and HCT15 cells (EC50s = 11.25, 13.17, 3.04, and 11.86 μM, respectively). Pulsatilla saponin D (6 mg/kg per day) reduces tumor volume in a murine Lewis lung carcinoma model. | | Chemical Properties | White powder, soluble in organic solvents such as methanol, ethanol, and DMSO, derived from Pulsatilla chinensis. | | Uses | Pulsatilla Saponin D shows antiangiogenic and antitumor activity. | | Definition | ChEBI: Pulsatilla saponin D is a triterpenoid. It has a role as a metabolite. | | in vivo | Pulsatilla saponin D (6.4 mg/kg) exhibits anti-tumor activity in Lewis lung carcinoma model[4]. | Animal Model: | 2x2x2 mm3 tumor fragments of a Lewis lung carcinoma (LLC) transplanted s.c. into the auxiliary region of the BDF1 mice[4]. | | Dosage: | 6.4 mg/kg. | | Administration: | Intraperitoneally on the 1 st to 7 th and 9 th to 14 th day. | | Result: | Had such a potent antitumor effect (IR, 82 %) on a solid tumor, which is higher than Adriamycin (IR, 64%). |
| | References | [1] SEONG-CHEOL BANG. Antitumor activity of Pulsatilla koreana saponins and their structure-activity relationship.[J]. Chemical & pharmaceutical bulletin, 2005, 53 11: 1451-1454. DOI: 10.1248/cpb.53.1451 |
| | Hederagenin 3-O-α-L-rhaMnopyranosyl(1→2)-(β-D-glucopyranosyl(1→4))-α-L-arabinopyranoside Preparation Products And Raw materials |
|